Get my own profile
Public access
View all20 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Maurizio ScaltritiAstraZenecaVerified email at astrazeneca.com
- Lewis CantleyDana Farber Cancer Center and Harvard Medical SchoolVerified email at med.cornell.edu
- Eneda Toska, PhDJohns Hopkins University School of MedicineVerified email at jhmi.edu
- David M HymanLoxo Oncology, Eli LillyVerified email at loxooncology.com
- Robert P. SebraProfessor, Genetics & Genomic Sciences, Icahn School of Medicine at Mount SinaiVerified email at mssm.edu
- Marcus D GoncalvesWeill Cornell New York Presbyterian HospitalVerified email at med.cornell.edu
- Seo-Kyoung HwangPfizerVerified email at Pfizer.com
- Alexander N GorelickHarvard Medical SchoolVerified email at hms.harvard.edu
- Nancy J Francoeur, PhDIcahn School of Medicine at Mount SinaiVerified email at icahn.mssm.edu
- Roger J LiangUT SouthwesternVerified email at utsouthwestern.edu
- Navid NahiyaanTechnician, Weill Cornell MedicineVerified email at med.cornell.edu
- Lukas DowAssociate Professor, Meyer Cancer Center, Weill Cornell MedicineVerified email at med.cornell.edu
- Alyna KattiRevolution MedicinesVerified email at revmed.com
- Samuel TaylorGraduate Student, Tri-Institutional PhD ProgramVerified email at med.cornell.edu
- Lajos PusztaiYale School of MedicineVerified email at yale.edu
- Roy S. Herbst, MD, PhDYale School of Medicine | Yale Cancer Center | Smilow Cancer Hospital at Yale-New HavenVerified email at yale.edu
- Roman YelenskyCTO, Gritstone OncologyVerified email at gritstone.com
- William Fraser SymmansProfessor of Pathology, University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
- Peter NovickUCSDVerified email at ucsd.edu
- karin m reinischyaleVerified email at yale.edu